Prediction of Toxicities Induced by Sorafenib and Regorafenib. Precision Medicine Communications, [S. l.], v. 2, n. 2, p. 85–89, 2022. DOI: 10.55627/pmc.002.02.0171. Disponível em: https://rootspress.org/journals/index.php/PMC/article/view/171. Acesso em: 8 may. 2026.